Cantargia to hold webcast briefing on recently announced rights issue
· Cantargia rights issue webcast to take place on July 7, 2022 at 2:00 PM CET/8:00 AM ET · Recently presented positive clinical results in non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC) · Capital to advance development in NSCLC and PDAC trials and other opportunities Cantargia AB (Cantargia AB; Nasdaq Stockholm: CANTA) today issued an invitation to attend a webcast on its recently announced fully covered rights issue. The text of the invitation is as follows: Cantargia invites you to register for and attend an online briefing (webcast) on Cantargia’s recently